Market Research Logo

Urinary Incontinence Drugs - Market Trends & Insights

Urinary Incontinence Drugs - Market Trends & Insights

This report presents Insights into the Urinary Incontinence Drugs Market. Illustrated with 10 data tables, the report comprises of a brief statistical summarization of the global market including North America, Europe, and US. Also included are global competitive player market shares.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


1. INTRODUCTION
2. MARKET OVERVIEW
Table 1: Urinary Incontinence Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies
Table 2: Urology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Basic Drainage, Catheter Stabilization, Continence, Temperature Management, and Urological Specialties
Table 3: Urology Market by Category in North America and Europe (2014) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis/Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers
Table 4: Prevalence of Urinary Incontinence by Gender in the US (2015) - Percentage Share Breakdown for Men and Women
Table 5: Prevalence of Urinary Incontinence in Women (Age Group (18-44)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience
Table 6: Prevalence of Urinary Incontinence in Women (Age Group (>60)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience
Table 7: Urinary Incontinence Drugs Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)
Table 8: Prevalence of Overactive Bladder (OAB) in Women (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience
Table 9: Prevalence of Overactive Bladder (OAB) in Men (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience
3. COMPETITIVE LANDSCAPE
Table 10: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others
4. APPENDIX

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report